首页> 外文期刊>Scandinavian journal of urology >Kidney cancer in Sweden: A decrease in incidence and tumour stage, 1979-2001
【24h】

Kidney cancer in Sweden: A decrease in incidence and tumour stage, 1979-2001

机译:瑞典肾脏癌:发病率和肿瘤分期的减少,1979-2001年

获取原文
获取原文并翻译 | 示例
           

摘要

Objective. In the Western world the incidence of renal cell carcinoma (RCC) has been increasing for several decades. In Sweden the incidence has decreased since 1980. This may reflect better health of the population. Another possible explanation could be a decrease in incidentally diagnosed RCC. Since these tumours are smaller, relatively more advanced tumours would then enter the cancer registry. The aim of this study was to compare methods of detection of RCC, tumour characteristics and survival from three periods over a timespan of more than 20 years. Material and methods. Adult patients (n = 515) with RCC were identified in a well-defined population-based area with the same incidence of RCC as the rest of Sweden. Patient data from three periods, 1979-1981 (A), 1989-1991 (B) and 1999-2001 (C), were collected for gender, age, tumour side, method of detection, tumour size, tumour type, metastasis, T stage and Fuhrman grade at the time of diagnosis. Using the Swedish Cause-of-Death Register, cause-specific survival was calculated. When available, tissue was reanalysed according to modern standards by an experienced pathologist. Results.The frequency of ultrasound and computed tomography increased and autopsy and intravenous pyelography decreased with time as the first detection method. There was a significant change towards smaller tumours and less severe stages and grades in more recent periods. Metastatic disease was most common in the first period. The distribution between the different histological tumour types did not change over time. Five-year cause-specific survival increased significantly from 41% to 63%. Subgroup analysis found significantly increased survival for patients with no metastases or with low-grade tumours. Conclusion. The data support a true decrease in the incidence of RCC over time in Sweden with a migration towards lower tumour stages but no change in distribution between the different histological subtypes over time.
机译:目的。在西方世界,肾细胞癌(RCC)的发病率已经增长了几十年。自1980年以来,瑞典的发病率有所下降。这可能反映出该国人口的健康状况。另一个可能的解释可能是偶然诊断的RCC减少。由于这些肿瘤较小,因此相对较晚期的肿瘤将进入癌症登记处。这项研究的目的是比较20多年来跨三个时期的RCC,肿瘤特征和存活率的检测方法。材料与方法。在一个明确的以人群为基础的地区确定了患有RCC的成年患者(n = 515),其RCC发生率与瑞典其他地区相同。收集了1979-1981年(A),1989-1991年(B)和1999-2001年(C)这三个时期的患者数据,包括性别,年龄,肿瘤侧,检测方法,肿瘤大小,肿瘤类型,转移,T阶段和诊断时的Fuhrman等级。使用瑞典死亡原因登记簿,可以计算特定原因的生存期。如果有的话,由经验丰富的病理学家根据现代标准对组织进行重新分析。结果:超声和计算机断层扫描的频率随着时间的增长而增加,尸检和静脉肾盂造影术随着时间的推移而减少。在最近的时期中,朝向较小的肿瘤和较不严重的阶段和等级发生了显着变化。转移性疾病最常见于第一期。不同组织学肿瘤类型之间的分布不会随时间变化。五年特定原因生存率从41%显着提高到63%。亚组分析发现,无转移或低级别肿瘤的患者的生存率显着提高。结论。数据表明,随着时间的推移,瑞典的RCC发生率随着时间的推移而确实下降,并且向较低的肿瘤阶段迁移,但是随着时间的推移,不同组织学亚型之间的分布没有变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号